EVALUATION OF THE COST SAVING POTENTIAL OF INTRODUCING AN ADALIMUMAB BIOSIMILAR FOR THE TREATMENT OF ALL LICENSED ADULT ADALIMUMAB INDICATIONS IN SPAIN

被引：1
|
作者：
Barbado, G. [1 ]
Waker, M. [2 ]
Levysohn, A. [3 ]
Bodin, M. [3 ]
Keady, S. [3 ]
机构：
[1] Biogen Spain SL, Madrid, Spain
[2] MTW Consultancy Ltd, London, England
[3] Biogen Int GmbH, Baar, Switzerland
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.104
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PBI21
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 41 条
  • [31] Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain
    Schlueter, Max
    Finn, Elaine
    Diaz, Silvia
    Dilla, Tatiana
    Inciarte-Mundo, Jose
    Fakhouri, Walid
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2019, 11 : 395 - 403
  • [32] A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
    Chen, Y-F
    Jobanputra, P.
    Barton, P.
    Jowett, S.
    Bryan, S.
    Clark, W.
    Fry-Smith, A.
    Burls, A.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2006, 10 (42) : 1 - +
  • [33] Evaluation of adalimumab biosimilar in treatment of psoriatic arthritis with concomitant moderate to severe chronic plaque psoriasis: An open-labeled, prospective, pilot case series
    Khandpur, Sujay
    Sondhi, Prateek
    Taneja, Neha
    Sharma, Preeti
    Das, Dayasagar
    Sharma, Alpana
    Sreenivas, Vishnubatla
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) : 248 - 251
  • [34] A COST-EFFECTIVENESS MODELING EVALUATION COMPARING ORIGINATOR FOLLITROPIN ALFA TO A BIOSIMILAR FOR THE TREATMENT OF INFERTILITY IN GERMANY, ITALY AND SPAIN
    Gizzo, S.
    Ferrando, M.
    Lispi, M.
    Nieto, Alvarez J.
    Bilger, W.
    Ripellino, C.
    Cataldo, N.
    Eheberg, D.
    Buehler, K.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A519 - A520
  • [35] A REAL LIFE RETROSPECTIVE ANALYSIS OF DRUG EXPENDITURE REVEALS NO SIGNIFICANT COST DIFFERENCE BETWEEN INFLIXIMAB AND ADALIMUMAB IN THE TREATMENT OF ADULT CROHN'S DISEASE
    Lamb, C. A.
    Price, M.
    Robinson, M.
    Gunn, M. C.
    Thompson, N. P.
    Mansfield, J. C.
    [J]. GUT, 2011, 60
  • [36] COST PER RESPONSE FOR ABATACEPT COMPARED WITH ADALIMUMAB IN THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS BASED ON ANTI-CITRULLINATED PROTEIN ANTIBODY TITRES IN ITALY, SPAIN AND CANADA
    Foo, J.
    Mennini, F.
    Heredia, J. M. Rodriguez
    Choquette, D.
    Attina, G.
    Merino, S. Jimenez
    Mtibaa, M.
    Alemao, E.
    Gaultney, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 415 - 415
  • [37] Pharmacokinetic Evaluation of a Proposed Adalimumab Biosimilar MSB11022 versus the US-Licensed Reference Product: Results of a Randomized, Double-Blind, 3-Arm Parallel-Group, Single-Dose Trial in Healthy Subjects
    Dryja, Anna
    Buccarello, Anna Lucia
    Gaillard, Isabelle
    Monnet, Joelle
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2824 - 2826
  • [38] PHARMACOKINETIC EVALUATION OF A PROPOSED ADALIMUMAB BIOSIMILAR MSB11022 VERSUS THE US-LICENSED REFERENCE PRODUCT: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, 3-ARM PARALLEL-GROUP, SINGLE-DOSE TRIAL IN HEALTHY SUBJECTS
    Dryja, Anna
    Buccarello, Anna L.
    Gaillard, Isabelle
    Monnet, Joelle
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S1218 - S1218
  • [39] COST-EFFICACY ANALYSIS OF LICENSED DRUGS FOR THE TREATMENT OF METASTATIC CASTRATE RESISTANT PROSTATE CANCER POST DOCETAXEL BASED ON HOSPITAL DRUG EVALUATION METHODOLOGY IN SPAIN
    Ostale, S.
    Ruiz, P.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A417 - A417
  • [40] Long-term cost-effectiveness of tight control for Crohn's disease with adalimumab-based treatment: economic evaluation beyond 48 weeks of CALM trial
    Panaccione, R.
    Colombel, J-F.
    Bossuyt, P.
    Baert, F.
    Vanasek, T.
    Danalioglu, A.
    Novacek, G.
    Armuzzi, A.
    Reinisch, W.
    Johnson, S.
    Buessing, M.
    Neimark, E.
    Petersson, J.
    Robinson, A. M.
    Thakkar, R. B.
    Lee, W-J.
    Skup, M.
    D'Haens, G.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S74 - S75
12345